These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 4260266
1. Demethylation and cleavage of glycosidic bonds of 4'''-methyldigoxin in man. Rietbrock N, Rennekamp C, Rennekamp H, von Bergmann K, Abshagen U. Naunyn Schmiedebergs Arch Pharmacol; 1972; 272(4):450-3. PubMed ID: 4260266 [No Abstract] [Full Text] [Related]
2. Pharmacokinetic behaviour of 4'''-methyldigoxin in man. Rennekamp H, Rennekamp C, Abshagen U, von Bergmann K, Rietbrock N. Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):172-4. PubMed ID: 4260801 [No Abstract] [Full Text] [Related]
3. Effects of pretreatment with spironolactone on pharmacokinetics of 4'''-methyldigoxin in rats. Abshagen U. Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):91-100. PubMed ID: 4267969 [No Abstract] [Full Text] [Related]
5. Disposition of beta-methyldigoxin in man. Rietbrock N, Abshagen U, Bergmann K, Rennekamp H. Eur J Clin Pharmacol; 1975 Dec 19; 9(2-3):105-14. PubMed ID: 1233258 [Abstract] [Full Text] [Related]
6. Metabolism of 3H-digoxin and some acetyl-digoxins: time-dependent formation of hydrophilic metabolites after oral application in man. Dwenger A, Haberland G. Naunyn Schmiedebergs Arch Pharmakol; 1971 Dec 19; 270(1):102-4. PubMed ID: 4253058 [No Abstract] [Full Text] [Related]
9. Pharmacokinetics and metabolism of alpha-acetyldigoxin in man. Bodem G, Wirth K, Gernand E, Dengler HJ. Arch Int Pharmacodyn Ther; 1974 Mar 19; 208(1):102-16. PubMed ID: 4846188 [No Abstract] [Full Text] [Related]
12. [Determination of the absorption and catabolism rate as well as of the full-effect and maintenance dosage of -methyldigoxin in decompensated heart patients]. Krämer KD, Hochrein H. Klin Wochenschr; 1972 Nov 01; 50(21):1009-14. PubMed ID: 4637343 [No Abstract] [Full Text] [Related]
13. Assessment of the biologic availability of digoxin in man. Fleckenstein L, Kroening B, Weintraub M. Clin Pharmacol Ther; 1974 Sep 01; 16(3):435-43. PubMed ID: 4606249 [No Abstract] [Full Text] [Related]
14. Pharmacokinetics of beta-methyldigoxin in healthy humans II: Oral studies and bioavailability. Hinderling PH, Garrett ER, Wester RC. J Pharm Sci; 1977 Mar 01; 66(3):314-25. PubMed ID: 845795 [Abstract] [Full Text] [Related]
15. Pharmacokinetics of beta-methyldigoxin in healthy humans I: intravenous studies. Hinderling PH, Garrett ER, Wester RD. J Pharm Sci; 1977 Feb 01; 66(2):242-53. PubMed ID: 839422 [Abstract] [Full Text] [Related]
16. Formation and disposition of bis- and monoglycosides after administration of 3H-4'''-methyldigoxin to man. Abshagen U, Rennekamp H, Küchler R, Rietbrock N. Eur J Clin Pharmacol; 1974 Feb 01; 7(3):177-81. PubMed ID: 4852077 [No Abstract] [Full Text] [Related]
17. Absorption of digoxin from different oral preparations in normal subjects during steady state. Huffman DH, Manion CV, Azarnoff DL. Clin Pharmacol Ther; 1974 Aug 01; 16(2):310-7. PubMed ID: 4850376 [No Abstract] [Full Text] [Related]
18. Equivalent bioavailability from digoxin elixir and rapid-dissolution tablets. Greenblatt DJ, Duhme DW, Koch-Weser J, Smith TW. JAMA; 1974 Sep 23; 229(13):1774-6. PubMed ID: 4479121 [No Abstract] [Full Text] [Related]
19. Bioavailability and pharmacokinetics of beta-methyldigoxin after multiple oral and intravenous doses. Rietbrock N, Guggenmos J, Kuhlmann J, Hess U. Eur J Clin Pharmacol; 1976 Mar 22; 09(5-6):373-9. PubMed ID: 971702 [Abstract] [Full Text] [Related]
20. Bioavailability of digoxin: what the clinician needs to know. Greenblatt DJ, Duhme DW, Koch-Weser J, Smith TW. Conn Med; 1974 May 22; 38(5):230-2. PubMed ID: 4831099 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]